Your session is about to expire
← Back to Search
Symptomatic for Gastroesophageal Reflux Disease
N/A
Waitlist Available
Led By Rena Yadlapati, M.D.
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4
Awards & highlights
No Placebo-Only Group
Summary
This study plans to learn more about reflux associated laryngeal symptoms, and more efficient ways to diagnose and treat this condition.
Eligible Conditions
- Gastroesophageal Reflux Disease
- Laryngopharyngeal Reflux
- Acid Reflux
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 4
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Patient-reported Symptom Response to Treatment Measured by the Reflux Symptom Index (RSI) Score
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: SymptomaticExperimental Treatment1 Intervention
This study examines the efficacy of the upper esophageal sphincter assist device as an adjunct to Proton-pump inhibitors (PPI) therapy in symptomatic subjects. (Reflux Band® Upper Esophageal Sphincter (UES) Assist Device)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Reflux Band® Upper Esophageal Sphincter (UES) Assist Device
2018
N/A
~50
Find a Location
Who is running the clinical trial?
University of California, San DiegoLead Sponsor
1,181 Previous Clinical Trials
1,575,676 Total Patients Enrolled
Rena Yadlapati, M.D.Principal Investigator - University of California, San Diego
University of California, San Diego
Share this study with friends
Copy Link
Messenger